# gene therapies (audio feeds) — RSS Amplifier Recent posts from the 5 feeds in the RSS Amplifier directory that cover gene therapies. Page: Feed: --- ## [Big Pharma Wants the Drug, Not Your Company | Ep. 1059](https://bowtiedbiotech.substack.com/p/big-pharma-wants-the-drug-not-your) _2026-08-20 · BowTiedBiotech_ Why Pharma Is Rewriting the Rules of Therapeutic Development, Asset by Asset ## [Outset Medical's 90 percent wipeout risk | Ep. 1058](https://bowtiedbiotech.substack.com/p/outset-medicals-90-percent-wipeout) _2026-08-19 · BowTiedBiotech_ Is the HCA Refresh Finally the Inflection? [Listen](https://api.substack.com/feed/podcast/211900020/eece030fed895918470a91636ec7ec8b.mp3) ## [BIOTECH MARKET RESEARCH $OM | Ep. 1057](https://bowtiedbiotech.substack.com/p/biotech-market-research-om-ep-1057) _2026-08-18 · BowTiedBiotech_ Outset Medical ## [Your Weekly Biotech News Fix | Ep. 1056](https://bowtiedbiotech.substack.com/p/your-weekly-biotech-news-fix-ep-1056) _2026-08-14 · BowTiedBiotech_ The week of 8.10.2026 ## [The New Drug Developer Has a Balance Sheet | Ep. 1055](https://bowtiedbiotech.substack.com/p/the-new-drug-developer-has-a-balance) _2026-08-14 · BowTiedBiotech_ How private capital is changing which drugs get funded, who keeps the upside, and what investors should watch next. ## Curing Sickle Cell Before Life Begins _2026-08-13 · RARECast_ Sickle cell disease is caused by a single mutation in the beta-globin gene that leads to painful crises, anemia, and organ damage. Despite advances in treatment, it remains a devastating and often overlooked global health challenge, particularly in low-resource settings where children frequently go undiagnosed until life-threatening complications arise. The PERICLES project is an ambitious… [Listen](https://rss.art19.com/episodes/8ed1a96a-f60e-4ce9-b441-8ed3c53c8065.mp3?rss_browser=BAhJIhRSU1NBbXBsaWZpZXJCb3QGOgZFVA%3D%3D--6345a2e4a0991d4cbe92da92e0fa95ff9d12de2e) ## [Strategic Flexibility in FDA Cell and Gene Therapy Regulation | Ep. 1054](https://bowtiedbiotech.substack.com/p/strategic-flexibility-in-fda-cell) _2026-08-12 · BowTiedBiotech_ FDA Overhauls Gene Therapy Manufacturing Rules [Listen](https://api.substack.com/feed/podcast/210851808/93111050755d76d454dba6a23e6523a7.mp3) ## [BIOTECH MARKET RESEARCH $AMLX | Ep. 1053](https://bowtiedbiotech.substack.com/p/biotech-market-research-amlx-ep-1053) _2026-08-11 · BowTiedBiotech_ Amylyx Pharmaceuticals ## [Programmable Immunity | Ep. 1052](https://bowtiedbiotech.substack.com/p/programmable-immunity-ep-1052) _2026-08-09 · BowTiedBiotech_ The Real Opportunity in In-Vivo CAR Therapies ## [BowTiedBiotech: A Constructive Week for the Sector | Ep. 1051](https://bowtiedbiotech.substack.com/p/bowtiedbiotech-a-constructive-week) _2026-08-08 · BowTiedBiotech_ Capital surges in an unforgiving biotech market [Listen](https://api.substack.com/feed/podcast/210357025/7225541541ffcd8f6522dad646e5d129.mp3) ## [Brisk AI News Briefings (Sponsored)](https://crawlproof.com/a/LmtTdFlGQMC5) _2026-08-08 · **Sponsored**_ Read AI summaries and listen to audio briefings for top stories. ## [Your Weekly Biotech News Fix | Ep. 1050](https://bowtiedbiotech.substack.com/p/your-weekly-biotech-news-fix-ep-1050) _2026-08-07 · BowTiedBiotech_ The week of 8.3.2026 ## [The Drug Supply Chain Is Running Out of Water | Ep. 1049](https://bowtiedbiotech.substack.com/p/the-drug-supply-chain-is-running) _2026-08-06 · BowTiedBiotech_ Europe’s drought is turning rivers, cooling systems, and industrial water into hidden constraints on therapeutic development ## Spotting Neuromuscular Red Flags _2026-08-06 · RARECast_ Many older adults may dismiss dropping objects, struggling with stairs, or tiring on short walks as a matter of just getting older, but it can be an early sign of a serious group of disorders known as late-onset neuromuscular diseases (LONDs). The American Neuromuscular Foundation’s Why Behind Your Weakness campaign seeks to raise awareness of LONDs and the shared symptom patterns that too often… [Listen](https://rss.art19.com/episodes/e4ca370d-4c65-4723-a10a-8974e4e15747.mp3?rss_browser=BAhJIhRSU1NBbXBsaWZpZXJCb3QGOgZFVA%3D%3D--6345a2e4a0991d4cbe92da92e0fa95ff9d12de2e) ## [Breaking the Career Ladder: The Future of Entry-Level Work | Ep. 1048](https://bowtiedbiotech.substack.com/p/breaking-the-career-ladder-the-future) _2026-08-05 · BowTiedBiotech_ How AI breaks the corporate ladder [Listen](https://api.substack.com/feed/podcast/209969455/9b7faa3476f2588d0232cc2f0edcae77.mp3) ## [The Last Shot Strategy | Ep. 1047](https://bowtiedbiotech.substack.com/p/the-last-shot-strategy-ep-1047) _2026-08-02 · BowTiedBiotech_ What Happens When Biotech Goes Virtual to Survive ## [Biotech Market Review: Clinical Outcomes and Commercial Execution | Ep. 1046](https://bowtiedbiotech.substack.com/p/biotech-market-review-clinical-outcomes) _2026-08-02 · BowTiedBiotech_ Scientific Theory Versus Brutal Market Reality [Listen](https://api.substack.com/feed/podcast/209442787/e979517dc67eb182000c1f2e4dea12a9.mp3) ## [Your Weekly Biotech News Fix | Ep. 1045](https://bowtiedbiotech.substack.com/p/your-weekly-biotech-news-fix-ep-1045) _2026-08-02 · BowTiedBiotech_ The week of 7.27.2026 ## Expanding into a Global Rare Disease Player through Deal-Driven Innovation _2026-07-30 · RARECast_ Chiesi Global Rare Diseases has rapidly evolved from a small, regional rare‑disease business into a global organization, leveraging strategic deals and development bets to reshape standards of care for patients worldwide. Giacomo Chiesi, head of the unit, discusses how the business has grown through acquisitions, its move into CRISPR gene editing and blood–brain barrier‑crossing enzyme platforms,… [Listen](https://rss.art19.com/episodes/e4ec8a3c-c76e-41e4-9d3e-e0261673f219.mp3?rss_browser=BAhJIhRSU1NBbXBsaWZpZXJCb3QGOgZFVA%3D%3D--6345a2e4a0991d4cbe92da92e0fa95ff9d12de2e) ## [Internal Innovation or Strategic Sourcing? | Ep. 1043](https://bowtiedbiotech.substack.com/p/internal-innovation-or-strategic) _2026-07-26 · BowTiedBiotech_ Rethinking Pharma's Growth Engine ## [BIOTECH MARKET RESEARCH $SLN | Ep. 1044](https://bowtiedbiotech.substack.com/p/biotech-market-research-sln-ep-1044) _2026-07-26 · BowTiedBiotech_ SIlence Therapeutics ## [Meet Claude, the AI assistant (Sponsored)](https://crawlproof.com/a/6DYXuuDNI9Qr) _2026-07-26 · **Sponsored**_ Conversational AI to answer questions, brainstorm ideas, and help with tasks. ## [Biotech Pulse: Clinical Trials, M&A, and Regulatory Risk | Ep. 1042](https://bowtiedbiotech.substack.com/p/biotech-pulse-clinical-trials-m-and) _2026-07-25 · BowTiedBiotech_ The Billion Dollar Biotech Reality Check [Listen](https://api.substack.com/feed/podcast/208394827/88efae5c69803a4079778aa4c49277d6.mp3) ## [Your Weekly Biotech News Fix | Ep. 1041](https://bowtiedbiotech.substack.com/p/your-weekly-biotech-news-fix-ep-1041) _2026-07-24 · BowTiedBiotech_ The week of 7.20.2026 ## [The Peptide Underground Is Running Biotech’s Cheapest Human Experiment | Ep. 1040](https://bowtiedbiotech.substack.com/p/the-peptide-underground-is-running) _2026-07-23 · BowTiedBiotech_ The FDA crackdown on compounded peptides could reveal the next real therapeutic platform hiding inside the wellness market. ## When Geography, Cost, and Policy Become as Life-Limiting as a Disease _2026-07-23 · RARECast_ When Tom Sayiner was diagnosed with the fatal neurodegenerative disease ALS, he and his wife, Tamara, learned that tofersen had been approved in Europe as a therapy that could slow the progression of his genetic form of the disease. But the Sayiners, who live in Sweden, soon discovered they could not access the drug because a Swedish health technology assessment council determined there was… [Listen](https://rss.art19.com/episodes/ba4cd802-900a-4076-9c2b-370821734baa.mp3?rss_browser=BAhJIhRSU1NBbXBsaWZpZXJCb3QGOgZFVA%3D%3D--6345a2e4a0991d4cbe92da92e0fa95ff9d12de2e) ## [The Invisible Factory: The Hidden Biotech Supply Chain | Ep. 1039](https://bowtiedbiotech.substack.com/p/the-invisible-factory-the-hidden) _2026-07-22 · BowTiedBiotech_ Biotech Companies Do Not Make Drugs [Listen](https://api.substack.com/feed/podcast/208108108/7038b1d5dcc7f688b7248d4c07be100d.mp3) ## [Liquidity, Beta, and the Biotech Edge | Ep. 1038](https://bowtiedbiotech.substack.com/p/liquidity-beta-and-the-biotech-edge) _2026-07-19 · BowTiedBiotech_ Finding Alpha When the Herd Gets Whiplashed ## A One-Time Cell Therapy to Reset the Immune System in Autoimmune Diseases _2026-07-16 · RARECast_ People with rare, severe autoimmune diseases often live for years with progressive, disabling conditions managed by chronic immunosuppression that rarely addresses the underlying cause. Kyverna is developing an autologous CAR T-cell therapy designed to deliver a deep immune reset by broadly depleting pathogenic B cells, followed by repopulation with naïve, non-pathogenic B cells and normalization… [Listen](https://rss.art19.com/episodes/315ac594-9982-4a63-b6e1-1f38273d97f3.mp3?rss_browser=BAhJIhRSU1NBbXBsaWZpZXJCb3QGOgZFVA%3D%3D--6345a2e4a0991d4cbe92da92e0fa95ff9d12de2e) ## [Inflammation at the Helm | Ep. 1037](https://bowtiedbiotech.substack.com/p/inflammation-at-the-helm-ep-1037) _2026-07-12 · BowTiedBiotech_ Reprogramming the Brain’s Immune Axis to Rewrite Neurodegeneration ## Building the Infrastructure for Made‑to‑Order Gene Therapies _2026-07-09 · RARECast_ The case of baby KJ Muldoon, an infant born with a lethal genetic metabolic disorder, demonstrates the potential to compress years of therapeutic development into months using an in vivo base editing approach. Jeff Coller, director of the Johns Hopkins RNA Innovation Center, wrote about the case in a New York Times op-ed, arguing that CRISPR-based base editors—delivered via lipid nanoparticles as… [Listen](https://rss.art19.com/episodes/c04217ff-31b9-49bd-a9db-6029e3be8d3b.mp3?rss_browser=BAhJIhRSU1NBbXBsaWZpZXJCb3QGOgZFVA%3D%3D--6345a2e4a0991d4cbe92da92e0fa95ff9d12de2e) ## Rewiring the Rare Disease Diagnostic Odyssey _2026-07-02 · RARECast_ Families seeking a diagnosis for a rare disease often face a protracted diagnostic odyssey that can include ER visits, specialist referrals, and dead ends, even at world-class medical centers. Parents bounce from doctor to doctor while payers absorb mounting costs, and the pivotal moment of putting a name to a disease—which can reduce unnecessary care and emotional distress—arrives late, if at… [Listen](https://rss.art19.com/episodes/59915023-9190-40c1-b6e1-3fca2bdc2f36.mp3?rss_browser=BAhJIhRSU1NBbXBsaWZpZXJCb3QGOgZFVA%3D%3D--6345a2e4a0991d4cbe92da92e0fa95ff9d12de2e) ## [Find it on Amazon (Sponsored)](https://crawlproof.com/a/Pikh2rPainJb) _2026-07-02 · **Sponsored**_ Open the Amazon product listing to see details and availability ## Emerging from a Life in the Shadows _2026-06-25 · RARECast_ Erythropoietic protoporphyria (EPP) is a rare, inherited metabolic disorder that triggers a toxic photochemical reaction in skin when exposed to light. A short time in the sun for someone with the condition can result in excruciating, second-degree–like burns and leaves patients sidelined from normal outdoor activity. Craig Leppert, who has EPP, saw his childhood shaped by constant vigilance… [Listen](https://rss.art19.com/episodes/6553f69c-d236-49a9-bf5d-c20f93c38c06.mp3?rss_browser=BAhJIhRSU1NBbXBsaWZpZXJCb3QGOgZFVA%3D%3D--6345a2e4a0991d4cbe92da92e0fa95ff9d12de2e) ## Fitting Big Genes into Small Vectors _2026-06-18 · RARECast_ Many disease‑causing genes are too large to be packaged into standard AAV gene therapy vectors, leaving a long list of otherwise gene-therapy-ready conditions without viable treatments. SpliceBio is leveraging a protein splicing platform based on engineered split inteins to overcome the cargo limitations of AAV gene therapy vectors, enabling delivery of large genes to potentially treat a broad… [Listen](https://rss.art19.com/episodes/a15f067f-1fb9-44f0-b55a-7caf1c75ccce.mp3?rss_browser=BAhJIhRSU1NBbXBsaWZpZXJCb3QGOgZFVA%3D%3D--6345a2e4a0991d4cbe92da92e0fa95ff9d12de2e) ## Targeting Iron Dysregulation in the Neurodegenerative Condition MSA _2026-06-11 · RARECast_ Multiple system atrophy is a rapidly progressive neurodegenerative condition that is often misdiagnosed as Parkinson’s disease but carries a far grimmer prognosis. MSA has a median survival of just seven to eight years after symptom onset. Toxic aggregates of alpha‑synuclein and excess brain iron create a vicious cycle of neuronal damage that drives the multisystem motor and autonomic decline… [Listen](https://rss.art19.com/episodes/a6c068d5-76bc-4ae4-937e-5fd3cf614ae7.mp3?rss_browser=BAhJIhRSU1NBbXBsaWZpZXJCb3QGOgZFVA%3D%3D--6345a2e4a0991d4cbe92da92e0fa95ff9d12de2e) ## [Solving Patient Matching in Rare Disease Trials](https://podcasters.spotify.com/pod/show/rare-diseases-roundup/episodes/Solving-Patient-Matching-in-Rare-Disease-Trials-e3ikuml) _2026-04-29 · Partners4Access · P4A Let's Talk Rare: The Life Science Podcast_ One of the most persistent barriers in rare disease drug development isn’t the science — it’s identifying and reaching the small number of patients who could benefit from emerging therapies. Without solving this, even the most promising innovations risk never reaching the people who need them most. In our latest podcast episode, we explore how the industry can better connect patients to clinical… [Listen](https://anchor.fm/s/47fe5f0/podcast/play/119224469/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-3-29%2F4adba2de-76d1-9e64-1bb0-b05bd5959d49.mp3) ## [Rare Disease Day Special: The stats and stories you need to hear.](https://podcasters.spotify.com/pod/show/rare-diseases-roundup/episodes/Rare-Disease-Day-Special-The-stats-and-stories-you-need-to-hear-e3fmdtf) _2026-02-27 · Partners4Access · P4A Let's Talk Rare: The Life Science Podcast_ Rare Disease Day Special | Let’s Talk Rare This Rare Disease Day, Let’s Talk Rare releases a special episode focused on the data and real-world context behind rare diseases. The episode features Iro Malekous , consultant at Partners4Access, who discusses: Key statistics shaping the rare disease landscape What those numbers mean for patients and families Gaps in diagnosis, access, and treatment Why… [Listen](https://anchor.fm/s/47fe5f0/podcast/play/116127087/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-1-27%2F29d3b49f-a6a4-4001-acd3-8adcb90596c3.mp3) ## [2026 Trends: A Year Of Change & Opportunity](https://podcasters.spotify.com/pod/show/rare-diseases-roundup/episodes/2026-Trends-A-Year-Of-Change--Opportunity-e3ed70j) _2026-01-30 · Partners4Access · P4A Let's Talk Rare: The Life Science Podcast_ 26 isn’t just another year in market access — it’s a turning point. In this episode of Let’s Talk Rare , P4A dives into the trends that are about to reshape how rare disease therapies reach patients across Europe — and trust us, the ground is moving. Policy is back in the spotlight. With the EU Pharmaceutical Strategy resurfacing, the big question is: How do we reward innovation and keep medicines… [Listen](https://anchor.fm/s/47fe5f0/podcast/play/114776531/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-0-30%2F9da5038d-a70e-e543-7377-e583bc5e9610.mp3) ## [Going To Glasgow: ISPOR 2025](https://podcasters.spotify.com/pod/show/rare-diseases-roundup/episodes/Going-To-Glasgow-ISPOR-2025-e3boohr) _2025-12-02 · Partners4Access · P4A Let's Talk Rare: The Life Science Podcast_ In this episode of Let’s Talk Rare , we looked back at P4A’s recent trip to Glasgow, where our colleagues, Sam Morrison & Iro Malekou were on the ground for ISPOR activities leading up to ISPOR 2025 . They weren’t just observing—they were actively contributing , presenting a poster abstract , connecting with experts, and taking the pulse of what’s shaping the HEOR and rare disease landscape. We… [Listen](https://anchor.fm/s/47fe5f0/podcast/play/112009211/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2025-11-2%2F879a4337-6c46-3a09-b63b-c8561cb07d5c.mp3) ## [Conversations Beyond the Clinic](https://podcasters.spotify.com/pod/show/rare-diseases-roundup/episodes/Conversations-Beyond-the-Clinic-e3ae3ms) _2025-11-03 · Partners4Access · P4A Let's Talk Rare: The Life Science Podcast_ Recorded live from ESMO 2025, Conversations Beyond the Clinic explores the different perspectives of the attendees and stakeholders at the ESMO conference in Berlin. We asked a variety of medical stakeholders including A.I experts, nurses, researchers, patients and more to share their experiences of the conference and the work that brought them to ESMO. Through candid conversations we uncovers how… [Listen](https://anchor.fm/s/47fe5f0/podcast/play/110611612/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2025-10-3%2F9ed8cb17-3893-d4c9-341b-1d582c928bcf.mp3) ## [Voices Uncovered: Understanding Mental Health in Rare Diseases using Social Listening](https://podcasters.spotify.com/pod/show/rare-diseases-roundup/episodes/Voices-Uncovered-Understanding-Mental-Health-in-Rare-Diseases-using-Social-Listening-e38reqd) _2025-09-29 · Partners4Access · P4A Let's Talk Rare: The Life Science Podcast_ In this episode, we tune into the unfiltered voices of patients and caregivers navigating life with rare conditions. Through the power of social listening, we uncover the hidden struggles around mental health—stories often left unsaid in clinics but shared openly online. Joined by Lauren Roberts from Rareminds, we explore what these conversations reveal, why they matter, and how they can reshape… [Listen](https://anchor.fm/s/47fe5f0/podcast/play/108951821/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2025-8-29%2F19d6b6a9-7c25-d370-784a-9e47cfa7449a.mp3) ## [Stronger Together: Collaborating for Better Patient Information with Catherine Richards Golini](https://podcasters.spotify.com/pod/show/rare-diseases-roundup/episodes/Stronger-Together-Collaborating-for-Better-Patient-Information-with-Catherine-Richards-Golini-e37bi61) _2025-08-26 · Partners4Access · P4A Let's Talk Rare: The Life Science Podcast_ How do we make sure patients receive health information that is clear, trustworthy, and truly helpful? We sit down with Catherine Richards Golini from Karger Publishers to explore the power of collaboration in creating impactful patient resources. From working with healthcare professionals and patient advocates to partnering with researchers and publishers, Catherine shares how involving multiple… [Listen](https://anchor.fm/s/47fe5f0/podcast/play/107382401/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2025-7-26%2Fb2172e60-90b0-1fa2-f70e-7c62bf30e0df.mp3) ## [OST-HER2 and the Fight Against Osteosarcoma: A New Hope After 40 Years](https://podcasters.spotify.com/pod/show/rare-diseases-roundup/episodes/OST-HER2-and-the-Fight-Against-Osteosarcoma-A-New-Hope-After-40-Years-e34us43) _2025-07-01 · Partners4Access · P4A Let's Talk Rare: The Life Science Podcast_ Join us as we sit down with Paul Romness of OS Therapies to explore an exciting breakthrough in OST-HER2 targeted therapies for osteosarcoma —a rare and aggressive bone cancer. Learn how this innovative approach is offering new hope to patients, advancing precision medicine, and pushing the boundaries of rare disease treatment, not just for humans but for dogs too. Joining the discussion as always… [Listen](https://anchor.fm/s/47fe5f0/podcast/play/104869443/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2025-6-1%2F20a96112-a335-f33a-d712-de012c6f1d96.mp3) ## [AI for Rare Disease: From Discovery to Trials, Smarter and Faster](https://podcasters.spotify.com/pod/show/rare-diseases-roundup/episodes/AI-for-Rare-Disease-From-Discovery-to-Trials--Smarter-and-Faster-e33h87f) _2025-05-29 · Partners4Access · P4A Let's Talk Rare: The Life Science Podcast_ Discover how artificial intelligence is transforming the future of rare disease research in the latest episode of Let’s Talk Rare , the official podcast from Partners4Access (P4A). Join us as we sit down with Ilya Burkov, AI expert at Nebius to explore how cutting-edge machine learning tools are accelerating the discovery, diagnosis, and development of treatments for rare conditions. With over 300… [Listen](https://anchor.fm/s/47fe5f0/podcast/play/103374511/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2025-4-29%2F4dd73bf9-45a1-743a-6de0-b47dc82f116d.mp3) ## [Improving Alignment In Drug Development](https://podcasters.spotify.com/pod/show/rare-diseases-roundup/episodes/Improving-Alignment-In-Drug-Development-e323l4o) _2025-04-28 · Partners4Access · P4A Let's Talk Rare: The Life Science Podcast_ In the latest episode of Let's Talk Rare, Owen Bryant & Georgie Rack delve into the world of drug development in rare diseases. They are joined by the brilliant Rob Freishtat, president of Uncommon Cures. Rob brings unique insights on who the key stakeholder are in developing drugs and the many ways that we can bring them together in order to improve and enhance the delivery of much-needed… [Listen](https://anchor.fm/s/47fe5f0/podcast/play/101880408/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2025-3-28%2Fd8fb1005-13d7-ac88-3ad4-2552aa0bb179.mp3) ## [#45-Cell and Gene Therapy Today](https://cgtnewsletter.substack.com/p/45-cell-and-gene-therapy-today) _2025-03-06 · Pedro Silva Couto · Cell and Gene Therapy Today_ Stay up to date with the latest developments in your field with our weekly digest of industry news and research articles. ## [#44-Cell and Gene Therapy Today](https://cgtnewsletter.substack.com/p/44-cell-and-gene-therapy-today) _2025-02-13 · Pedro Silva Couto · Cell and Gene Therapy Today_ Stay up to date with the latest developments in your field with our weekly digest of industry news and research articles. ## [#43-Cell and Gene Therapy Today](https://cgtnewsletter.substack.com/p/43-cell-and-gene-therapy-today) _2025-01-30 · Pedro Silva Couto · Cell and Gene Therapy Today_ Stay up to date with the latest developments in your field with our weekly digest of industry news and research articles. ## [#42-Cell and Gene Therapy Today](https://cgtnewsletter.substack.com/p/42-cell-and-gene-therapy-today) _2025-01-23 · Pedro Silva Couto · Cell and Gene Therapy Today_ Stay up to date with the latest developments in your field with our weekly digest of industry news and research articles. ## [#41-Cell and Gene Therapy Today](https://cgtnewsletter.substack.com/p/41-cell-and-gene-therapy-today) _2025-01-16 · Pedro Silva Couto · Cell and Gene Therapy Today_ Stay up to date with the latest developments in your field with our weekly digest of industry news and research articles. ## [#40-Cell and Gene Therapy Today](https://cgtnewsletter.substack.com/p/40-cell-and-gene-therapy-today) _2025-01-09 · Pedro Silva Couto · Cell and Gene Therapy Today_ Stay up to date with the latest developments in your field with our weekly digest of industry news and research articles. ## [#39-Cell and Gene Therapy Today](https://cgtnewsletter.substack.com/p/39-cell-and-gene-therapy-today) _2025-01-02 · Pedro Silva Couto · Cell and Gene Therapy Today_ Stay up to date with the latest developments in your field with our weekly digest of industry news and research articles.